Results 101 to 110 of about 11,189 (206)

BROMOCRIPTINE FOR VISUAL FIELD DEFECTS IN PROLACTINOMAS [PDF]

open access: yes, 2014
The introduction of bromocriptine (2-brocergocryptine mesylate), a semi-synthetic ergot alkaloid, has revolutionised the treatment of the amenorrhoeagalactorrhoea syndrome due ...
Mustaffa Embong
core  

Comparison of the effects of cabergoline and bromocriptine in women with hyperprolactinemic amenorrhea [PDF]

open access: yes, 2008
Objective: There are relatively few reports in the world comparing the beneficial and adverse effects of bromocriptine and cabergoline in the treatment of hyperprolactinemic patients and there is also lack of such studies in Iraq.
Mahmood, Isam H.   +2 more
core   +3 more sources

The effects of vaginal bromocriptine and dienogest on women with adenomyosis: a clinical study

open access: yesMiddle East Fertility Society Journal
Objective Adenomyosis occurs when endometrial glands and stroma develop in the myometrium, leading to symptoms such as pelvic pain and heavy menstrual bleeding. Method This randomized, double-blinded, controlled trial study was conducted on patients with
Parvane Bahoorzahi   +4 more
doaj   +1 more source

The determination of additive effect and intraocular pressure lowering effects of 0.05% bromocriptine and 0.25% timolol [PDF]

open access: yes, 1997
5th Congress of the European-Glaucoma-Society -- JUN 19-22, 1996 -- PARIS, FRANCEIt has been confirmed that topically applied bromocriptine has a satisfactory intraocular pressure (IOP) lowering effect without serious ocular or systemic side effects.
Demircan, S   +4 more
core  

The rapid diagnosis of sensitivity or resistance to dopamine agonists with depot bromocriptine. [PDF]

open access: yes, 1987
Some patients with hyperprolactinaemia are unable to tolerate even low doses of oral bromocriptine. In such cases, it is difficult to predict whether serum prolactin might be normalized if higher doses could be tolerated, or whether true resistance to ...
Grossman, Ashley   +3 more
core  

Severe Iatrogenic Tricuspid Regurgitation. [PDF]

open access: yesCureus
Amaral Pinto I, Macedo D, Rei Neto R.
europepmc   +1 more source

Chinese consensus on the diagnosis and treatment of prolactinomas (2025 edition). [PDF]

open access: yesChin Neurosurg J
Lin S   +18 more
europepmc   +1 more source

Treatment of patients with prolactinomas [PDF]

open access: yes, 1978
Fahlbusch, R.   +5 more
core   +1 more source

Home - About - Disclaimer - Privacy